.jpg)
EU-UK Spotlight: Renewables, trade, and the global supply chain
Hogan Lovells advises HealthCare Royalty Partners on Apnimed’s US$150 million debt financing
Press releases
| 05
May
2026
Philadelphia, Washington, D.C. – Global law firm Hogan Lovells has advised HealthCare Royalty Partners (HCRx) in connection with a senior secured credit facility for up to US$150 million with Apnimed, Inc., a pharmaceutical company developing novel oral therapies for obstructive sleep apnea (OSA).
The capital is expected to support commercial readiness activities and the planned U.S. launch of Apnimed’s lead product candidate, AD109, if approved by the U.S. Food and Drug Administration (FDA).
Read more about the transaction here.
The Hogan Lovells cross-practice deal team was led by partner Conor Larkin (M&A, Philadelphia / Houston), with partners Matt Schernecke (Banking & Loan Finance, New York), Stephen Nicolai (Capital Markets, Philadelphia), Barry Burgdorf (M&A, Houston), counsel Hank Watsky (IP, Northern Virginia), senior associates Gibby Baker (M&A, Philadelphia) and Michael Basse (Banking & Loan Finance, Washington, D.C.), and associate Amy Isselmann (General Corporate & Finance, Philadelphia).
Contacts
Press contacts
